nodes	percent_of_prediction	percent_of_DWPC	metapath
Disopyramide—SLC22A2—Cladribine—multiple sclerosis	0.231	0.348	CbGbCtD
Disopyramide—SLC22A1—Cladribine—multiple sclerosis	0.2	0.302	CbGbCtD
Disopyramide—CYP3A4—Fingolimod—multiple sclerosis	0.0571	0.0861	CbGbCtD
Disopyramide—CYP3A4—Methylprednisolone—multiple sclerosis	0.0368	0.0555	CbGbCtD
Disopyramide—CYP3A4—Triamcinolone—multiple sclerosis	0.0279	0.042	CbGbCtD
Disopyramide—CYP3A4—Mitoxantrone—multiple sclerosis	0.0268	0.0405	CbGbCtD
Disopyramide—CYP3A4—Betamethasone—multiple sclerosis	0.0239	0.0361	CbGbCtD
Disopyramide—CYP3A4—Prednisolone—multiple sclerosis	0.0236	0.0356	CbGbCtD
Disopyramide—CYP3A4—Prednisone—multiple sclerosis	0.0223	0.0336	CbGbCtD
Disopyramide—CYP3A4—Dexamethasone—multiple sclerosis	0.0139	0.021	CbGbCtD
Disopyramide—KCND2—brainstem—multiple sclerosis	0.0038	0.0827	CbGeAlD
Disopyramide—KCND3—brainstem—multiple sclerosis	0.00331	0.0721	CbGeAlD
Disopyramide—KCND2—medulla oblongata—multiple sclerosis	0.00265	0.0577	CbGeAlD
Disopyramide—KCND2—midbrain—multiple sclerosis	0.00242	0.0527	CbGeAlD
Disopyramide—KCND2—spinal cord—multiple sclerosis	0.00236	0.0515	CbGeAlD
Disopyramide—KCND3—midbrain—multiple sclerosis	0.00211	0.046	CbGeAlD
Disopyramide—KCND2—nervous system—multiple sclerosis	0.00199	0.0434	CbGeAlD
Disopyramide—KCND2—central nervous system—multiple sclerosis	0.00192	0.0417	CbGeAlD
Disopyramide—KCND2—cerebellum—multiple sclerosis	0.00187	0.0408	CbGeAlD
Disopyramide—KCND3—nervous system—multiple sclerosis	0.00174	0.0378	CbGeAlD
Disopyramide—KCND3—central nervous system—multiple sclerosis	0.00167	0.0364	CbGeAlD
Disopyramide—KCND3—cerebellum—multiple sclerosis	0.00163	0.0356	CbGeAlD
Disopyramide—KCND2—brain—multiple sclerosis	0.00152	0.0331	CbGeAlD
Disopyramide—KCND3—brain—multiple sclerosis	0.00133	0.0289	CbGeAlD
Disopyramide—ORM1—spinal cord—multiple sclerosis	0.00113	0.0246	CbGeAlD
Disopyramide—SCN5A—nervous system—multiple sclerosis	0.00104	0.0227	CbGeAlD
Disopyramide—SCN5A—central nervous system—multiple sclerosis	0.001	0.0218	CbGeAlD
Disopyramide—ORM1—nervous system—multiple sclerosis	0.000952	0.0207	CbGeAlD
Disopyramide—ORM1—central nervous system—multiple sclerosis	0.000916	0.0199	CbGeAlD
Disopyramide—CHRM2—nervous system—multiple sclerosis	0.000888	0.0193	CbGeAlD
Disopyramide—SLC22A1—nervous system—multiple sclerosis	0.000872	0.019	CbGeAlD
Disopyramide—CHRM2—central nervous system—multiple sclerosis	0.000855	0.0186	CbGeAlD
Disopyramide—SLC22A1—central nervous system—multiple sclerosis	0.000839	0.0183	CbGeAlD
Disopyramide—CHRM1—nervous system—multiple sclerosis	0.000808	0.0176	CbGeAlD
Disopyramide—SCN5A—brain—multiple sclerosis	0.000797	0.0173	CbGeAlD
Disopyramide—CHRM1—central nervous system—multiple sclerosis	0.000778	0.0169	CbGeAlD
Disopyramide—CHRM3—nervous system—multiple sclerosis	0.000723	0.0157	CbGeAlD
Disopyramide—CHRM3—central nervous system—multiple sclerosis	0.000696	0.0151	CbGeAlD
Disopyramide—CHRM2—brain—multiple sclerosis	0.000678	0.0148	CbGeAlD
Disopyramide—SLC22A1—brain—multiple sclerosis	0.000666	0.0145	CbGeAlD
Disopyramide—CHRM1—brain—multiple sclerosis	0.000618	0.0134	CbGeAlD
Disopyramide—CHRM3—brain—multiple sclerosis	0.000553	0.012	CbGeAlD
Disopyramide—Erectile dysfunction—Prednisone—multiple sclerosis	0.00045	0.00224	CcSEcCtD
Disopyramide—Rash—Cladribine—multiple sclerosis	0.000447	0.00222	CcSEcCtD
Disopyramide—Dermatitis—Cladribine—multiple sclerosis	0.000446	0.00222	CcSEcCtD
Disopyramide—Weight increased—Prednisone—multiple sclerosis	0.000444	0.00221	CcSEcCtD
Disopyramide—Anorexia—Mitoxantrone—multiple sclerosis	0.000444	0.00221	CcSEcCtD
Disopyramide—Headache—Cladribine—multiple sclerosis	0.000444	0.00221	CcSEcCtD
Disopyramide—Arrhythmia—Triamcinolone—multiple sclerosis	0.000442	0.0022	CcSEcCtD
Disopyramide—Vision blurred—Prednisolone—multiple sclerosis	0.000441	0.0022	CcSEcCtD
Disopyramide—Arrhythmia—Methylprednisolone—multiple sclerosis	0.000441	0.00219	CcSEcCtD
Disopyramide—Hypotension—Mitoxantrone—multiple sclerosis	0.000435	0.00217	CcSEcCtD
Disopyramide—Ill-defined disorder—Prednisolone—multiple sclerosis	0.000435	0.00216	CcSEcCtD
Disopyramide—Depression—Prednisone—multiple sclerosis	0.000434	0.00216	CcSEcCtD
Disopyramide—Angioedema—Prednisolone—multiple sclerosis	0.000428	0.00213	CcSEcCtD
Disopyramide—Malaise—Prednisolone—multiple sclerosis	0.000422	0.0021	CcSEcCtD
Disopyramide—Dysgeusia—Triamcinolone—multiple sclerosis	0.000422	0.0021	CcSEcCtD
Disopyramide—Nausea—Cladribine—multiple sclerosis	0.000421	0.00209	CcSEcCtD
Disopyramide—Vertigo—Prednisolone—multiple sclerosis	0.000421	0.00209	CcSEcCtD
Disopyramide—Syncope—Prednisolone—multiple sclerosis	0.00042	0.00209	CcSEcCtD
Disopyramide—Paraesthesia—Mitoxantrone—multiple sclerosis	0.000418	0.00208	CcSEcCtD
Disopyramide—Dyspnoea—Mitoxantrone—multiple sclerosis	0.000415	0.00207	CcSEcCtD
Disopyramide—Somnolence—Mitoxantrone—multiple sclerosis	0.000414	0.00206	CcSEcCtD
Disopyramide—Loss of consciousness—Prednisolone—multiple sclerosis	0.000412	0.00205	CcSEcCtD
Disopyramide—Dyspepsia—Mitoxantrone—multiple sclerosis	0.00041	0.00204	CcSEcCtD
Disopyramide—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000405	0.00202	CcSEcCtD
Disopyramide—Fatigue—Mitoxantrone—multiple sclerosis	0.000402	0.002	CcSEcCtD
Disopyramide—Arrhythmia—Dexamethasone—multiple sclerosis	0.000401	0.002	CcSEcCtD
Disopyramide—Arrhythmia—Betamethasone—multiple sclerosis	0.000401	0.002	CcSEcCtD
Disopyramide—Ill-defined disorder—Triamcinolone—multiple sclerosis	0.0004	0.00199	CcSEcCtD
Disopyramide—Ill-defined disorder—Methylprednisolone—multiple sclerosis	0.000399	0.00198	CcSEcCtD
Disopyramide—Pain—Mitoxantrone—multiple sclerosis	0.000398	0.00198	CcSEcCtD
Disopyramide—Constipation—Mitoxantrone—multiple sclerosis	0.000398	0.00198	CcSEcCtD
Disopyramide—Bradycardia—Prednisone—multiple sclerosis	0.000398	0.00198	CcSEcCtD
Disopyramide—CYP3A4—nervous system—multiple sclerosis	0.000397	0.00865	CbGeAlD
Disopyramide—Diarrhoea—Azathioprine—multiple sclerosis	0.000394	0.00196	CcSEcCtD
Disopyramide—Discomfort—Prednisolone—multiple sclerosis	0.000394	0.00196	CcSEcCtD
Disopyramide—Angioedema—Triamcinolone—multiple sclerosis	0.000394	0.00196	CcSEcCtD
Disopyramide—Angioedema—Methylprednisolone—multiple sclerosis	0.000393	0.00195	CcSEcCtD
Disopyramide—Malaise—Triamcinolone—multiple sclerosis	0.000388	0.00193	CcSEcCtD
Disopyramide—Malaise—Methylprednisolone—multiple sclerosis	0.000388	0.00193	CcSEcCtD
Disopyramide—Vertigo—Triamcinolone—multiple sclerosis	0.000387	0.00193	CcSEcCtD
Disopyramide—Syncope—Triamcinolone—multiple sclerosis	0.000386	0.00192	CcSEcCtD
Disopyramide—Vertigo—Methylprednisolone—multiple sclerosis	0.000386	0.00192	CcSEcCtD
Disopyramide—Syncope—Methylprednisolone—multiple sclerosis	0.000385	0.00192	CcSEcCtD
Disopyramide—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000384	0.00191	CcSEcCtD
Disopyramide—CYP3A4—central nervous system—multiple sclerosis	0.000382	0.00832	CbGeAlD
Disopyramide—Oedema—Prednisolone—multiple sclerosis	0.000382	0.0019	CcSEcCtD
Disopyramide—Dysuria—Methotrexate—multiple sclerosis	0.000382	0.0019	CcSEcCtD
Disopyramide—Neutropenia—Methotrexate—multiple sclerosis	0.000382	0.0019	CcSEcCtD
Disopyramide—Dizziness—Azathioprine—multiple sclerosis	0.000381	0.0019	CcSEcCtD
Disopyramide—Loss of consciousness—Triamcinolone—multiple sclerosis	0.000379	0.00188	CcSEcCtD
Disopyramide—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.000378	0.00188	CcSEcCtD
Disopyramide—Shock—Prednisolone—multiple sclerosis	0.000376	0.00187	CcSEcCtD
Disopyramide—Erectile dysfunction—Methotrexate—multiple sclerosis	0.000376	0.00187	CcSEcCtD
Disopyramide—Urticaria—Mitoxantrone—multiple sclerosis	0.00037	0.00184	CcSEcCtD
Disopyramide—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000369	0.00184	CcSEcCtD
Disopyramide—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000368	0.00183	CcSEcCtD
Disopyramide—Vomiting—Azathioprine—multiple sclerosis	0.000366	0.00182	CcSEcCtD
Disopyramide—Drowsiness—Methotrexate—multiple sclerosis	0.000364	0.00181	CcSEcCtD
Disopyramide—Rash—Azathioprine—multiple sclerosis	0.000363	0.00181	CcSEcCtD
Disopyramide—Dermatitis—Azathioprine—multiple sclerosis	0.000363	0.00181	CcSEcCtD
Disopyramide—Depression—Methotrexate—multiple sclerosis	0.000363	0.00181	CcSEcCtD
Disopyramide—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000363	0.0018	CcSEcCtD
Disopyramide—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.000363	0.0018	CcSEcCtD
Disopyramide—Discomfort—Triamcinolone—multiple sclerosis	0.000362	0.0018	CcSEcCtD
Disopyramide—Discomfort—Methylprednisolone—multiple sclerosis	0.000361	0.0018	CcSEcCtD
Disopyramide—Headache—Azathioprine—multiple sclerosis	0.000361	0.0018	CcSEcCtD
Disopyramide—Dry mouth—Triamcinolone—multiple sclerosis	0.000359	0.00178	CcSEcCtD
Disopyramide—Angioedema—Dexamethasone—multiple sclerosis	0.000357	0.00178	CcSEcCtD
Disopyramide—Angioedema—Betamethasone—multiple sclerosis	0.000357	0.00178	CcSEcCtD
Disopyramide—Confusional state—Methylprednisolone—multiple sclerosis	0.000354	0.00176	CcSEcCtD
Disopyramide—Malaise—Dexamethasone—multiple sclerosis	0.000352	0.00175	CcSEcCtD
Disopyramide—Malaise—Betamethasone—multiple sclerosis	0.000352	0.00175	CcSEcCtD
Disopyramide—Oedema—Triamcinolone—multiple sclerosis	0.000351	0.00175	CcSEcCtD
Disopyramide—Vertigo—Dexamethasone—multiple sclerosis	0.000351	0.00175	CcSEcCtD
Disopyramide—Vertigo—Betamethasone—multiple sclerosis	0.000351	0.00175	CcSEcCtD
Disopyramide—Syncope—Dexamethasone—multiple sclerosis	0.00035	0.00174	CcSEcCtD
Disopyramide—Syncope—Betamethasone—multiple sclerosis	0.00035	0.00174	CcSEcCtD
Disopyramide—Arrhythmia—Prednisone—multiple sclerosis	0.000349	0.00174	CcSEcCtD
Disopyramide—Shock—Triamcinolone—multiple sclerosis	0.000346	0.00172	CcSEcCtD
Disopyramide—Insomnia—Prednisolone—multiple sclerosis	0.000346	0.00172	CcSEcCtD
Disopyramide—Shock—Methylprednisolone—multiple sclerosis	0.000345	0.00172	CcSEcCtD
Disopyramide—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000343	0.00171	CcSEcCtD
Disopyramide—Loss of consciousness—Betamethasone—multiple sclerosis	0.000343	0.00171	CcSEcCtD
Disopyramide—Paraesthesia—Prednisolone—multiple sclerosis	0.000343	0.00171	CcSEcCtD
Disopyramide—Nausea—Azathioprine—multiple sclerosis	0.000342	0.0017	CcSEcCtD
Disopyramide—Skin disorder—Methylprednisolone—multiple sclerosis	0.000341	0.0017	CcSEcCtD
Disopyramide—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.00034	0.00169	CcSEcCtD
Disopyramide—Agranulocytosis—Methotrexate—multiple sclerosis	0.00034	0.00169	CcSEcCtD
Disopyramide—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000339	0.00169	CcSEcCtD
Disopyramide—Asthenia—Mitoxantrone—multiple sclerosis	0.000334	0.00166	CcSEcCtD
Disopyramide—Discomfort—Dexamethasone—multiple sclerosis	0.000329	0.00164	CcSEcCtD
Disopyramide—Discomfort—Betamethasone—multiple sclerosis	0.000329	0.00164	CcSEcCtD
Disopyramide—Hypotension—Methylprednisolone—multiple sclerosis	0.000328	0.00163	CcSEcCtD
Disopyramide—Pain—Prednisolone—multiple sclerosis	0.000327	0.00163	CcSEcCtD
Disopyramide—Hepatitis—Methotrexate—multiple sclerosis	0.000327	0.00163	CcSEcCtD
Disopyramide—Vision blurred—Prednisone—multiple sclerosis	0.000321	0.0016	CcSEcCtD
Disopyramide—Oedema—Dexamethasone—multiple sclerosis	0.000319	0.00159	CcSEcCtD
Disopyramide—Oedema—Betamethasone—multiple sclerosis	0.000319	0.00159	CcSEcCtD
Disopyramide—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000319	0.00159	CcSEcCtD
Disopyramide—Insomnia—Triamcinolone—multiple sclerosis	0.000318	0.00158	CcSEcCtD
Disopyramide—Insomnia—Methylprednisolone—multiple sclerosis	0.000317	0.00158	CcSEcCtD
Disopyramide—Ill-defined disorder—Prednisone—multiple sclerosis	0.000316	0.00157	CcSEcCtD
Disopyramide—Paraesthesia—Triamcinolone—multiple sclerosis	0.000316	0.00157	CcSEcCtD
Disopyramide—Feeling abnormal—Prednisolone—multiple sclerosis	0.000315	0.00157	CcSEcCtD
Disopyramide—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000315	0.00157	CcSEcCtD
Disopyramide—Shock—Dexamethasone—multiple sclerosis	0.000314	0.00156	CcSEcCtD
Disopyramide—Shock—Betamethasone—multiple sclerosis	0.000314	0.00156	CcSEcCtD
Disopyramide—Dyspnoea—Triamcinolone—multiple sclerosis	0.000313	0.00156	CcSEcCtD
Disopyramide—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000312	0.00155	CcSEcCtD
Disopyramide—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000312	0.00155	CcSEcCtD
Disopyramide—Angioedema—Prednisone—multiple sclerosis	0.000311	0.00155	CcSEcCtD
Disopyramide—Dyspepsia—Triamcinolone—multiple sclerosis	0.000309	0.00154	CcSEcCtD
Disopyramide—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000309	0.00154	CcSEcCtD
Disopyramide—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000308	0.00153	CcSEcCtD
Disopyramide—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000308	0.00153	CcSEcCtD
Disopyramide—Malaise—Prednisone—multiple sclerosis	0.000307	0.00153	CcSEcCtD
Disopyramide—Vertigo—Prednisone—multiple sclerosis	0.000306	0.00152	CcSEcCtD
Disopyramide—Syncope—Prednisone—multiple sclerosis	0.000305	0.00152	CcSEcCtD
Disopyramide—Anorexia—Dexamethasone—multiple sclerosis	0.000304	0.00151	CcSEcCtD
Disopyramide—Anorexia—Betamethasone—multiple sclerosis	0.000304	0.00151	CcSEcCtD
Disopyramide—Urticaria—Prednisolone—multiple sclerosis	0.000304	0.00151	CcSEcCtD
Disopyramide—Fatigue—Triamcinolone—multiple sclerosis	0.000303	0.00151	CcSEcCtD
Disopyramide—Fatigue—Methylprednisolone—multiple sclerosis	0.000302	0.0015	CcSEcCtD
Disopyramide—Pain—Triamcinolone—multiple sclerosis	0.000301	0.0015	CcSEcCtD
Disopyramide—Loss of consciousness—Prednisone—multiple sclerosis	0.000299	0.00149	CcSEcCtD
Disopyramide—Hypotension—Betamethasone—multiple sclerosis	0.000298	0.00148	CcSEcCtD
Disopyramide—Hypotension—Dexamethasone—multiple sclerosis	0.000298	0.00148	CcSEcCtD
Disopyramide—Vomiting—Mitoxantrone—multiple sclerosis	0.000296	0.00147	CcSEcCtD
Disopyramide—Rash—Mitoxantrone—multiple sclerosis	0.000294	0.00146	CcSEcCtD
Disopyramide—Dermatitis—Mitoxantrone—multiple sclerosis	0.000293	0.00146	CcSEcCtD
Disopyramide—Headache—Mitoxantrone—multiple sclerosis	0.000292	0.00145	CcSEcCtD
Disopyramide—Feeling abnormal—Triamcinolone—multiple sclerosis	0.00029	0.00144	CcSEcCtD
Disopyramide—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000289	0.00144	CcSEcCtD
Disopyramide—Insomnia—Dexamethasone—multiple sclerosis	0.000288	0.00144	CcSEcCtD
Disopyramide—Insomnia—Betamethasone—multiple sclerosis	0.000288	0.00144	CcSEcCtD
Disopyramide—Paraesthesia—Dexamethasone—multiple sclerosis	0.000286	0.00142	CcSEcCtD
Disopyramide—Paraesthesia—Betamethasone—multiple sclerosis	0.000286	0.00142	CcSEcCtD
Disopyramide—Discomfort—Prednisone—multiple sclerosis	0.000286	0.00142	CcSEcCtD
Disopyramide—Dyspepsia—Dexamethasone—multiple sclerosis	0.000281	0.0014	CcSEcCtD
Disopyramide—Dyspepsia—Betamethasone—multiple sclerosis	0.000281	0.0014	CcSEcCtD
Disopyramide—Urticaria—Triamcinolone—multiple sclerosis	0.000279	0.00139	CcSEcCtD
Disopyramide—Urticaria—Methylprednisolone—multiple sclerosis	0.000279	0.00139	CcSEcCtD
Disopyramide—Dysgeusia—Methotrexate—multiple sclerosis	0.000279	0.00139	CcSEcCtD
Disopyramide—Body temperature increased—Triamcinolone—multiple sclerosis	0.000278	0.00138	CcSEcCtD
Disopyramide—Oedema—Prednisone—multiple sclerosis	0.000278	0.00138	CcSEcCtD
Disopyramide—Decreased appetite—Betamethasone—multiple sclerosis	0.000277	0.00138	CcSEcCtD
Disopyramide—Decreased appetite—Dexamethasone—multiple sclerosis	0.000277	0.00138	CcSEcCtD
Disopyramide—Nausea—Mitoxantrone—multiple sclerosis	0.000277	0.00138	CcSEcCtD
Disopyramide—Fatigue—Dexamethasone—multiple sclerosis	0.000275	0.00137	CcSEcCtD
Disopyramide—Fatigue—Betamethasone—multiple sclerosis	0.000275	0.00137	CcSEcCtD
Disopyramide—Shock—Prednisone—multiple sclerosis	0.000273	0.00136	CcSEcCtD
Disopyramide—Pain—Dexamethasone—multiple sclerosis	0.000273	0.00136	CcSEcCtD
Disopyramide—Pain—Betamethasone—multiple sclerosis	0.000273	0.00136	CcSEcCtD
Disopyramide—Skin disorder—Prednisone—multiple sclerosis	0.00027	0.00134	CcSEcCtD
Disopyramide—Hyperhidrosis—Prednisone—multiple sclerosis	0.000268	0.00134	CcSEcCtD
Disopyramide—Vision blurred—Methotrexate—multiple sclerosis	0.000268	0.00133	CcSEcCtD
Disopyramide—Anorexia—Prednisone—multiple sclerosis	0.000265	0.00132	CcSEcCtD
Disopyramide—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000264	0.00131	CcSEcCtD
Disopyramide—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000263	0.00131	CcSEcCtD
Disopyramide—Feeling abnormal—Betamethasone—multiple sclerosis	0.000263	0.00131	CcSEcCtD
Disopyramide—Malaise—Methotrexate—multiple sclerosis	0.000256	0.00128	CcSEcCtD
Disopyramide—Vertigo—Methotrexate—multiple sclerosis	0.000256	0.00127	CcSEcCtD
Disopyramide—Urticaria—Betamethasone—multiple sclerosis	0.000253	0.00126	CcSEcCtD
Disopyramide—Urticaria—Dexamethasone—multiple sclerosis	0.000253	0.00126	CcSEcCtD
Disopyramide—Dizziness—Prednisolone—multiple sclerosis	0.000253	0.00126	CcSEcCtD
Disopyramide—Asthenia—Triamcinolone—multiple sclerosis	0.000252	0.00125	CcSEcCtD
Disopyramide—Body temperature increased—Dexamethasone—multiple sclerosis	0.000252	0.00125	CcSEcCtD
Disopyramide—Body temperature increased—Betamethasone—multiple sclerosis	0.000252	0.00125	CcSEcCtD
Disopyramide—Asthenia—Methylprednisolone—multiple sclerosis	0.000252	0.00125	CcSEcCtD
Disopyramide—Insomnia—Prednisone—multiple sclerosis	0.000251	0.00125	CcSEcCtD
Disopyramide—Paraesthesia—Prednisone—multiple sclerosis	0.000249	0.00124	CcSEcCtD
Disopyramide—Pruritus—Triamcinolone—multiple sclerosis	0.000249	0.00124	CcSEcCtD
Disopyramide—Pruritus—Methylprednisolone—multiple sclerosis	0.000248	0.00123	CcSEcCtD
Disopyramide—Dyspepsia—Prednisone—multiple sclerosis	0.000244	0.00122	CcSEcCtD
Disopyramide—Chest pain—Methotrexate—multiple sclerosis	0.000242	0.0012	CcSEcCtD
Disopyramide—Decreased appetite—Prednisone—multiple sclerosis	0.000241	0.0012	CcSEcCtD
Disopyramide—Rash—Prednisolone—multiple sclerosis	0.000241	0.0012	CcSEcCtD
Disopyramide—Dermatitis—Prednisolone—multiple sclerosis	0.000241	0.0012	CcSEcCtD
Disopyramide—Diarrhoea—Methylprednisolone—multiple sclerosis	0.00024	0.00119	CcSEcCtD
Disopyramide—Fatigue—Prednisone—multiple sclerosis	0.000239	0.00119	CcSEcCtD
Disopyramide—Headache—Prednisolone—multiple sclerosis	0.000239	0.00119	CcSEcCtD
Disopyramide—Discomfort—Methotrexate—multiple sclerosis	0.000239	0.00119	CcSEcCtD
Disopyramide—Constipation—Prednisone—multiple sclerosis	0.000238	0.00118	CcSEcCtD
Disopyramide—Confusional state—Methotrexate—multiple sclerosis	0.000234	0.00116	CcSEcCtD
Disopyramide—Dizziness—Triamcinolone—multiple sclerosis	0.000232	0.00116	CcSEcCtD
Disopyramide—Dizziness—Methylprednisolone—multiple sclerosis	0.000232	0.00115	CcSEcCtD
Disopyramide—Feeling abnormal—Prednisone—multiple sclerosis	0.000229	0.00114	CcSEcCtD
Disopyramide—Asthenia—Dexamethasone—multiple sclerosis	0.000229	0.00114	CcSEcCtD
Disopyramide—Asthenia—Betamethasone—multiple sclerosis	0.000229	0.00114	CcSEcCtD
Disopyramide—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000227	0.00113	CcSEcCtD
Disopyramide—Nausea—Prednisolone—multiple sclerosis	0.000227	0.00113	CcSEcCtD
Disopyramide—Pruritus—Dexamethasone—multiple sclerosis	0.000226	0.00112	CcSEcCtD
Disopyramide—Pruritus—Betamethasone—multiple sclerosis	0.000226	0.00112	CcSEcCtD
Disopyramide—Skin disorder—Methotrexate—multiple sclerosis	0.000225	0.00112	CcSEcCtD
Disopyramide—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000224	0.00112	CcSEcCtD
Disopyramide—Vomiting—Triamcinolone—multiple sclerosis	0.000223	0.00111	CcSEcCtD
Disopyramide—Vomiting—Methylprednisolone—multiple sclerosis	0.000223	0.00111	CcSEcCtD
Disopyramide—Rash—Triamcinolone—multiple sclerosis	0.000222	0.0011	CcSEcCtD
Disopyramide—Dermatitis—Triamcinolone—multiple sclerosis	0.000221	0.0011	CcSEcCtD
Disopyramide—Anorexia—Methotrexate—multiple sclerosis	0.000221	0.0011	CcSEcCtD
Disopyramide—Rash—Methylprednisolone—multiple sclerosis	0.000221	0.0011	CcSEcCtD
Disopyramide—Dermatitis—Methylprednisolone—multiple sclerosis	0.000221	0.0011	CcSEcCtD
Disopyramide—Urticaria—Prednisone—multiple sclerosis	0.000221	0.0011	CcSEcCtD
Disopyramide—Headache—Triamcinolone—multiple sclerosis	0.00022	0.0011	CcSEcCtD
Disopyramide—Headache—Methylprednisolone—multiple sclerosis	0.00022	0.00109	CcSEcCtD
Disopyramide—Body temperature increased—Prednisone—multiple sclerosis	0.00022	0.00109	CcSEcCtD
Disopyramide—Diarrhoea—Dexamethasone—multiple sclerosis	0.000218	0.00109	CcSEcCtD
Disopyramide—Diarrhoea—Betamethasone—multiple sclerosis	0.000218	0.00109	CcSEcCtD
Disopyramide—Hypotension—Methotrexate—multiple sclerosis	0.000217	0.00108	CcSEcCtD
Disopyramide—Dizziness—Betamethasone—multiple sclerosis	0.000211	0.00105	CcSEcCtD
Disopyramide—Dizziness—Dexamethasone—multiple sclerosis	0.000211	0.00105	CcSEcCtD
Disopyramide—Insomnia—Methotrexate—multiple sclerosis	0.00021	0.00104	CcSEcCtD
Disopyramide—Nausea—Triamcinolone—multiple sclerosis	0.000209	0.00104	CcSEcCtD
Disopyramide—Paraesthesia—Methotrexate—multiple sclerosis	0.000208	0.00104	CcSEcCtD
Disopyramide—Nausea—Methylprednisolone—multiple sclerosis	0.000208	0.00104	CcSEcCtD
Disopyramide—Dyspnoea—Methotrexate—multiple sclerosis	0.000207	0.00103	CcSEcCtD
Disopyramide—Somnolence—Methotrexate—multiple sclerosis	0.000206	0.00103	CcSEcCtD
Disopyramide—Dyspepsia—Methotrexate—multiple sclerosis	0.000204	0.00102	CcSEcCtD
Disopyramide—Vomiting—Dexamethasone—multiple sclerosis	0.000203	0.00101	CcSEcCtD
Disopyramide—Vomiting—Betamethasone—multiple sclerosis	0.000203	0.00101	CcSEcCtD
Disopyramide—Decreased appetite—Methotrexate—multiple sclerosis	0.000202	0.001	CcSEcCtD
Disopyramide—Rash—Dexamethasone—multiple sclerosis	0.000201	0.001	CcSEcCtD
Disopyramide—Rash—Betamethasone—multiple sclerosis	0.000201	0.001	CcSEcCtD
Disopyramide—Dermatitis—Betamethasone—multiple sclerosis	0.000201	0.001	CcSEcCtD
Disopyramide—Dermatitis—Dexamethasone—multiple sclerosis	0.000201	0.001	CcSEcCtD
Disopyramide—Fatigue—Methotrexate—multiple sclerosis	0.0002	0.000996	CcSEcCtD
Disopyramide—Headache—Betamethasone—multiple sclerosis	0.0002	0.000994	CcSEcCtD
Disopyramide—Headache—Dexamethasone—multiple sclerosis	0.0002	0.000994	CcSEcCtD
Disopyramide—Asthenia—Prednisone—multiple sclerosis	0.000199	0.000992	CcSEcCtD
Disopyramide—Pain—Methotrexate—multiple sclerosis	0.000198	0.000988	CcSEcCtD
Disopyramide—Pruritus—Prednisone—multiple sclerosis	0.000196	0.000978	CcSEcCtD
Disopyramide—Feeling abnormal—Methotrexate—multiple sclerosis	0.000191	0.000952	CcSEcCtD
Disopyramide—Diarrhoea—Prednisone—multiple sclerosis	0.00019	0.000946	CcSEcCtD
Disopyramide—Nausea—Betamethasone—multiple sclerosis	0.000189	0.000943	CcSEcCtD
Disopyramide—Nausea—Dexamethasone—multiple sclerosis	0.000189	0.000943	CcSEcCtD
Disopyramide—Urticaria—Methotrexate—multiple sclerosis	0.000184	0.000918	CcSEcCtD
Disopyramide—Dizziness—Prednisone—multiple sclerosis	0.000184	0.000914	CcSEcCtD
Disopyramide—Body temperature increased—Methotrexate—multiple sclerosis	0.000183	0.000913	CcSEcCtD
Disopyramide—Vomiting—Prednisone—multiple sclerosis	0.000177	0.000879	CcSEcCtD
Disopyramide—Rash—Prednisone—multiple sclerosis	0.000175	0.000871	CcSEcCtD
Disopyramide—Dermatitis—Prednisone—multiple sclerosis	0.000175	0.000871	CcSEcCtD
Disopyramide—Headache—Prednisone—multiple sclerosis	0.000174	0.000866	CcSEcCtD
Disopyramide—Asthenia—Methotrexate—multiple sclerosis	0.000167	0.000829	CcSEcCtD
Disopyramide—Nausea—Prednisone—multiple sclerosis	0.000165	0.000821	CcSEcCtD
Disopyramide—Pruritus—Methotrexate—multiple sclerosis	0.000164	0.000817	CcSEcCtD
Disopyramide—Diarrhoea—Methotrexate—multiple sclerosis	0.000159	0.00079	CcSEcCtD
Disopyramide—Dizziness—Methotrexate—multiple sclerosis	0.000153	0.000764	CcSEcCtD
Disopyramide—Vomiting—Methotrexate—multiple sclerosis	0.000148	0.000734	CcSEcCtD
Disopyramide—Rash—Methotrexate—multiple sclerosis	0.000146	0.000728	CcSEcCtD
Disopyramide—Dermatitis—Methotrexate—multiple sclerosis	0.000146	0.000728	CcSEcCtD
Disopyramide—Headache—Methotrexate—multiple sclerosis	0.000145	0.000724	CcSEcCtD
Disopyramide—Nausea—Methotrexate—multiple sclerosis	0.000138	0.000686	CcSEcCtD
Disopyramide—CHRM1—Signaling by GPCR—CCR1—multiple sclerosis	6.53e-05	0.000729	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—CXCL13—multiple sclerosis	6.53e-05	0.000729	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—CCR1—multiple sclerosis	6.51e-05	0.000727	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—CXCL13—multiple sclerosis	6.51e-05	0.000727	CbGpPWpGaD
Disopyramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—multiple sclerosis	6.51e-05	0.000727	CbGpPWpGaD
Disopyramide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—multiple sclerosis	6.49e-05	0.000724	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—CCR1—multiple sclerosis	6.45e-05	0.00072	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—CXCL13—multiple sclerosis	6.45e-05	0.00072	CbGpPWpGaD
Disopyramide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6.42e-05	0.000717	CbGpPWpGaD
Disopyramide—SCN5A—Developmental Biology—TYK2—multiple sclerosis	6.4e-05	0.000715	CbGpPWpGaD
Disopyramide—SLC22A1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	6.19e-05	0.000691	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—GPC5—multiple sclerosis	6.07e-05	0.000678	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—TAGAP—multiple sclerosis	5.99e-05	0.000669	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—TAGAP—multiple sclerosis	5.97e-05	0.000666	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—TAGAP—multiple sclerosis	5.91e-05	0.00066	CbGpPWpGaD
Disopyramide—CHRM1—GPCR ligand binding—CCL5—multiple sclerosis	5.86e-05	0.000655	CbGpPWpGaD
Disopyramide—CHRM3—GPCR ligand binding—CCL5—multiple sclerosis	5.85e-05	0.000653	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—RRM1—multiple sclerosis	5.84e-05	0.000652	CbGpPWpGaD
Disopyramide—CHRM2—GPCR ligand binding—CCL5—multiple sclerosis	5.79e-05	0.000647	CbGpPWpGaD
Disopyramide—SCN5A—Axon guidance—MAPK1—multiple sclerosis	5.71e-05	0.000638	CbGpPWpGaD
Disopyramide—CHRM1—Regulation of Actin Cytoskeleton—MAPK1—multiple sclerosis	5.55e-05	0.00062	CbGpPWpGaD
Disopyramide—CHRM3—Regulation of Actin Cytoskeleton—MAPK1—multiple sclerosis	5.54e-05	0.000618	CbGpPWpGaD
Disopyramide—CHRM2—Regulation of Actin Cytoskeleton—MAPK1—multiple sclerosis	5.48e-05	0.000612	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—RRM1—multiple sclerosis	5.44e-05	0.000608	CbGpPWpGaD
Disopyramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	5.42e-05	0.000606	CbGpPWpGaD
Disopyramide—CHRM3—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	5.41e-05	0.000604	CbGpPWpGaD
Disopyramide—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	5.35e-05	0.000598	CbGpPWpGaD
Disopyramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	5.31e-05	0.000593	CbGpPWpGaD
Disopyramide—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	5.29e-05	0.000591	CbGpPWpGaD
Disopyramide—CHRM1—GPCR ligand binding—CCR5—multiple sclerosis	5.28e-05	0.00059	CbGpPWpGaD
Disopyramide—CHRM3—GPCR ligand binding—CCR5—multiple sclerosis	5.27e-05	0.000588	CbGpPWpGaD
Disopyramide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	5.24e-05	0.000585	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—S1PR1—multiple sclerosis	5.23e-05	0.000584	CbGpPWpGaD
Disopyramide—CHRM2—GPCR ligand binding—CCR5—multiple sclerosis	5.22e-05	0.000582	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—S1PR1—multiple sclerosis	5.22e-05	0.000582	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—S1PR1—multiple sclerosis	5.16e-05	0.000577	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—GPC5—multiple sclerosis	5.09e-05	0.000568	CbGpPWpGaD
Disopyramide—SLC22A2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	5.08e-05	0.000567	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—GPC5—multiple sclerosis	5.07e-05	0.000567	CbGpPWpGaD
Disopyramide—SCN5A—Developmental Biology—MMP9—multiple sclerosis	5.04e-05	0.000563	CbGpPWpGaD
Disopyramide—CHRM2—SIDS Susceptibility Pathways—TNF—multiple sclerosis	5.03e-05	0.000562	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—RRM1—multiple sclerosis	5.03e-05	0.000562	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—GPC5—multiple sclerosis	5.02e-05	0.000561	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—PTGER4—multiple sclerosis	4.93e-05	0.000551	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—PTGER4—multiple sclerosis	4.92e-05	0.000549	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—PTGER4—multiple sclerosis	4.87e-05	0.000544	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—CXCR3—multiple sclerosis	4.76e-05	0.000532	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—CXCR3—multiple sclerosis	4.75e-05	0.00053	CbGpPWpGaD
Disopyramide—SLC22A1—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	4.74e-05	0.000529	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—CXCR3—multiple sclerosis	4.7e-05	0.000525	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—CCL3—multiple sclerosis	4.65e-05	0.00052	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—CCL3—multiple sclerosis	4.64e-05	0.000518	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—CCR2—multiple sclerosis	4.63e-05	0.000517	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—CCR2—multiple sclerosis	4.62e-05	0.000516	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—CCL3—multiple sclerosis	4.59e-05	0.000513	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—CCR2—multiple sclerosis	4.57e-05	0.000511	CbGpPWpGaD
Disopyramide—SCN5A—Developmental Biology—STAT3—multiple sclerosis	4.48e-05	0.000501	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—PTGER4—multiple sclerosis	4.48e-05	0.0005	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—PTGER4—multiple sclerosis	4.46e-05	0.000499	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—RGS1—multiple sclerosis	4.45e-05	0.000497	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—RGS1—multiple sclerosis	4.43e-05	0.000495	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—PTGER4—multiple sclerosis	4.42e-05	0.000494	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—RGS1—multiple sclerosis	4.39e-05	0.00049	CbGpPWpGaD
Disopyramide—SCN5A—Axon guidance—IL6—multiple sclerosis	4.39e-05	0.00049	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—CXCR3—multiple sclerosis	4.33e-05	0.000483	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—CXCR3—multiple sclerosis	4.31e-05	0.000482	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—CNR1—multiple sclerosis	4.28e-05	0.000478	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—CXCR3—multiple sclerosis	4.27e-05	0.000477	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—CNR1—multiple sclerosis	4.26e-05	0.000476	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—CNR1—multiple sclerosis	4.22e-05	0.000471	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—GPR65—multiple sclerosis	4.22e-05	0.000471	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—CCR2—multiple sclerosis	4.21e-05	0.00047	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—GPR65—multiple sclerosis	4.2e-05	0.00047	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—CCR2—multiple sclerosis	4.19e-05	0.000468	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—GPR65—multiple sclerosis	4.16e-05	0.000465	CbGpPWpGaD
Disopyramide—SCN5A—Developmental Biology—TGFB1—multiple sclerosis	4.15e-05	0.000464	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—CCR2—multiple sclerosis	4.15e-05	0.000464	CbGpPWpGaD
Disopyramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	4.14e-05	0.000463	CbGpPWpGaD
Disopyramide—CHRM1—GPCR ligand binding—POMC—multiple sclerosis	4.13e-05	0.000461	CbGpPWpGaD
Disopyramide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	4.13e-05	0.000461	CbGpPWpGaD
Disopyramide—CHRM3—GPCR ligand binding—POMC—multiple sclerosis	4.12e-05	0.00046	CbGpPWpGaD
Disopyramide—CHRM2—GPCR ligand binding—POMC—multiple sclerosis	4.08e-05	0.000455	CbGpPWpGaD
Disopyramide—SCN5A—Developmental Biology—MAPK1—multiple sclerosis	4.07e-05	0.000455	CbGpPWpGaD
Disopyramide—CHRM2—SIDS Susceptibility Pathways—IL6—multiple sclerosis	4.06e-05	0.000453	CbGpPWpGaD
Disopyramide—CHRM1—GPCR ligand binding—CCL2—multiple sclerosis	4.04e-05	0.000451	CbGpPWpGaD
Disopyramide—CHRM3—GPCR ligand binding—CCL2—multiple sclerosis	4.03e-05	0.00045	CbGpPWpGaD
Disopyramide—CHRM2—GPCR ligand binding—CCL2—multiple sclerosis	3.99e-05	0.000445	CbGpPWpGaD
Disopyramide—SLC22A2—Neuronal System—MAPK1—multiple sclerosis	3.89e-05	0.000435	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—CNR1—multiple sclerosis	3.88e-05	0.000434	CbGpPWpGaD
Disopyramide—SCN5A—Developmental Biology—TNF—multiple sclerosis	3.88e-05	0.000433	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—CNR1—multiple sclerosis	3.87e-05	0.000432	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CXCL13—multiple sclerosis	3.86e-05	0.000431	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CCR1—multiple sclerosis	3.86e-05	0.000431	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—CXCL10—multiple sclerosis	3.85e-05	0.00043	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CCR1—multiple sclerosis	3.85e-05	0.000429	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CXCL13—multiple sclerosis	3.85e-05	0.000429	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—CXCL10—multiple sclerosis	3.84e-05	0.000429	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—CNR1—multiple sclerosis	3.83e-05	0.000428	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CXCL13—multiple sclerosis	3.81e-05	0.000425	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CCR1—multiple sclerosis	3.81e-05	0.000425	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—CXCL10—multiple sclerosis	3.8e-05	0.000424	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—SRM—multiple sclerosis	3.68e-05	0.000411	CbGpPWpGaD
Disopyramide—SLC22A1—Neuronal System—MAPK1—multiple sclerosis	3.63e-05	0.000405	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—CXCL10—multiple sclerosis	3.5e-05	0.00039	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—CXCL10—multiple sclerosis	3.49e-05	0.000389	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—CXCL10—multiple sclerosis	3.45e-05	0.000385	CbGpPWpGaD
Disopyramide—CYP3A4—Biological oxidations—POMC—multiple sclerosis	3.41e-05	0.000381	CbGpPWpGaD
Disopyramide—SLC22A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.37e-05	0.000377	CbGpPWpGaD
Disopyramide—CHRM1—Circadian rythm related genes—IL6—multiple sclerosis	3.36e-05	0.000375	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—BCHE—multiple sclerosis	3.35e-05	0.000375	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—CCL5—multiple sclerosis	3.31e-05	0.00037	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—CCL5—multiple sclerosis	3.3e-05	0.000369	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—CCL5—multiple sclerosis	3.27e-05	0.000365	CbGpPWpGaD
Disopyramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	3.18e-05	0.000355	CbGpPWpGaD
Disopyramide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	3.17e-05	0.000354	CbGpPWpGaD
Disopyramide—SLC22A1—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.14e-05	0.000351	CbGpPWpGaD
Disopyramide—SCN5A—Developmental Biology—IL6—multiple sclerosis	3.13e-05	0.00035	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—BCHE—multiple sclerosis	3.13e-05	0.000349	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—CCL5—multiple sclerosis	3.01e-05	0.000336	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—CCL5—multiple sclerosis	3e-05	0.000335	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—CCR5—multiple sclerosis	2.99e-05	0.000333	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—CCR5—multiple sclerosis	2.98e-05	0.000332	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—CCL5—multiple sclerosis	2.97e-05	0.000332	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—CCR5—multiple sclerosis	2.95e-05	0.000329	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—IL2RA—multiple sclerosis	2.94e-05	0.000329	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—IL2RA—multiple sclerosis	2.93e-05	0.000328	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—IL2RA—multiple sclerosis	2.9e-05	0.000324	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—BCHE—multiple sclerosis	2.89e-05	0.000323	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CCL3—multiple sclerosis	2.75e-05	0.000307	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CCL3—multiple sclerosis	2.74e-05	0.000306	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CCL3—multiple sclerosis	2.71e-05	0.000303	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—CCR5—multiple sclerosis	2.71e-05	0.000303	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—CCR5—multiple sclerosis	2.7e-05	0.000302	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—CCR5—multiple sclerosis	2.68e-05	0.000299	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—IL2RA—multiple sclerosis	2.67e-05	0.000298	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—IL2RA—multiple sclerosis	2.66e-05	0.000297	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—PTGER4—multiple sclerosis	2.65e-05	0.000295	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—IL2RA—multiple sclerosis	2.64e-05	0.000295	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PTGER4—multiple sclerosis	2.64e-05	0.000295	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PTGER4—multiple sclerosis	2.61e-05	0.000292	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—PGR—multiple sclerosis	2.61e-05	0.000291	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PGR—multiple sclerosis	2.6e-05	0.00029	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	2.59e-05	0.00029	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	2.59e-05	0.00029	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PGR—multiple sclerosis	2.57e-05	0.000287	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CXCR3—multiple sclerosis	2.56e-05	0.000285	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CXCR3—multiple sclerosis	2.55e-05	0.000284	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CD28—multiple sclerosis	2.53e-05	0.000283	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CD28—multiple sclerosis	2.52e-05	0.000282	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CXCR3—multiple sclerosis	2.52e-05	0.000282	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CD28—multiple sclerosis	2.5e-05	0.000279	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CCR2—multiple sclerosis	2.49e-05	0.000278	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CCR2—multiple sclerosis	2.48e-05	0.000277	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CCR2—multiple sclerosis	2.45e-05	0.000274	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GPC5—multiple sclerosis	2.37e-05	0.000265	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—POMC—multiple sclerosis	2.33e-05	0.000261	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—POMC—multiple sclerosis	2.33e-05	0.00026	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—POMC—multiple sclerosis	2.3e-05	0.000257	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CNR1—multiple sclerosis	2.29e-05	0.000256	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CNR1—multiple sclerosis	2.29e-05	0.000255	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CNR1—multiple sclerosis	2.26e-05	0.000253	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—POMC—multiple sclerosis	2.12e-05	0.000237	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—POMC—multiple sclerosis	2.11e-05	0.000236	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—POMC—multiple sclerosis	2.09e-05	0.000234	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—CCL2—multiple sclerosis	2.07e-05	0.000232	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—CCL2—multiple sclerosis	2.07e-05	0.000231	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CXCL10—multiple sclerosis	2.07e-05	0.000231	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CXCL10—multiple sclerosis	2.06e-05	0.00023	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—CCL2—multiple sclerosis	2.05e-05	0.000229	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CXCL10—multiple sclerosis	2.04e-05	0.000228	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—APOE—multiple sclerosis	2.02e-05	0.000225	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.97e-05	0.00022	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—TYK2—multiple sclerosis	1.88e-05	0.00021	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—APOE—multiple sclerosis	1.88e-05	0.00021	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—TYK2—multiple sclerosis	1.88e-05	0.00021	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—TYK2—multiple sclerosis	1.86e-05	0.000208	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CD86—multiple sclerosis	1.81e-05	0.000202	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CD86—multiple sclerosis	1.8e-05	0.000201	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CD86—multiple sclerosis	1.78e-05	0.000199	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CCL5—multiple sclerosis	1.78e-05	0.000199	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CCL5—multiple sclerosis	1.77e-05	0.000198	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CCL5—multiple sclerosis	1.76e-05	0.000196	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—APOE—multiple sclerosis	1.74e-05	0.000194	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—POMC—multiple sclerosis	1.73e-05	0.000194	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—IL2—multiple sclerosis	1.73e-05	0.000193	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—IL2—multiple sclerosis	1.72e-05	0.000192	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—IL2—multiple sclerosis	1.7e-05	0.00019	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—SPP1—multiple sclerosis	1.65e-05	0.000184	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—SPP1—multiple sclerosis	1.64e-05	0.000183	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—SPP1—multiple sclerosis	1.63e-05	0.000182	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—POMC—multiple sclerosis	1.62e-05	0.00018	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CCR5—multiple sclerosis	1.6e-05	0.000179	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CCR5—multiple sclerosis	1.6e-05	0.000178	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CCR5—multiple sclerosis	1.58e-05	0.000177	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—ALB—multiple sclerosis	1.58e-05	0.000176	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—IL2RA—multiple sclerosis	1.58e-05	0.000176	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—IL2RA—multiple sclerosis	1.57e-05	0.000176	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—IL2—multiple sclerosis	1.57e-05	0.000175	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—IL2—multiple sclerosis	1.56e-05	0.000174	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—IL2RA—multiple sclerosis	1.56e-05	0.000174	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—IL2—multiple sclerosis	1.55e-05	0.000173	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—POMC—multiple sclerosis	1.49e-05	0.000167	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—ALB—multiple sclerosis	1.47e-05	0.000164	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—APOE—multiple sclerosis	1.46e-05	0.000163	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—APOE—multiple sclerosis	1.45e-05	0.000162	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—APOE—multiple sclerosis	1.44e-05	0.000161	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—ALB—multiple sclerosis	1.36e-05	0.000152	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CD80—multiple sclerosis	1.32e-05	0.000147	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CD80—multiple sclerosis	1.31e-05	0.000147	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CD80—multiple sclerosis	1.3e-05	0.000145	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—POMC—multiple sclerosis	1.25e-05	0.00014	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—POMC—multiple sclerosis	1.25e-05	0.000139	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—POMC—multiple sclerosis	1.24e-05	0.000138	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CCL2—multiple sclerosis	1.22e-05	0.000137	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CCL2—multiple sclerosis	1.22e-05	0.000136	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CCL2—multiple sclerosis	1.21e-05	0.000135	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—MAPK1—multiple sclerosis	1.2e-05	0.000134	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—MAPK1—multiple sclerosis	1.19e-05	0.000133	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—MAPK1—multiple sclerosis	1.18e-05	0.000132	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—BCHE—multiple sclerosis	1.13e-05	0.000126	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—TYK2—multiple sclerosis	1.11e-05	0.000124	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—TYK2—multiple sclerosis	1.11e-05	0.000124	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—TYK2—multiple sclerosis	1.1e-05	0.000123	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—IL2—multiple sclerosis	9.25e-06	0.000103	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—IL2—multiple sclerosis	9.23e-06	0.000103	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—IL6—multiple sclerosis	9.21e-06	0.000103	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—IL6—multiple sclerosis	9.18e-06	0.000103	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—IL2—multiple sclerosis	9.14e-06	0.000102	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—IL6—multiple sclerosis	9.09e-06	0.000102	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—MMP9—multiple sclerosis	8.76e-06	9.78e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—MMP9—multiple sclerosis	8.73e-06	9.75e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—MMP9—multiple sclerosis	8.65e-06	9.66e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—STAT3—multiple sclerosis	7.79e-06	8.7e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—STAT3—multiple sclerosis	7.76e-06	8.67e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—STAT3—multiple sclerosis	7.69e-06	8.59e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—MYC—multiple sclerosis	7.24e-06	8.08e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—TGFB1—multiple sclerosis	7.22e-06	8.06e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—MYC—multiple sclerosis	7.21e-06	8.06e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—TGFB1—multiple sclerosis	7.2e-06	8.04e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—MYC—multiple sclerosis	7.14e-06	7.98e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—TGFB1—multiple sclerosis	7.13e-06	7.96e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—MAPK1—multiple sclerosis	7.08e-06	7.91e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—MAPK1—multiple sclerosis	7.06e-06	7.88e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—MAPK1—multiple sclerosis	6.99e-06	7.8e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—APOE—multiple sclerosis	6.79e-06	7.58e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—POMC—multiple sclerosis	5.83e-06	6.52e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—IL6—multiple sclerosis	5.44e-06	6.08e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—IL6—multiple sclerosis	5.42e-06	6.06e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—IL6—multiple sclerosis	5.37e-06	6e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—ALB—multiple sclerosis	5.32e-06	5.94e-05	CbGpPWpGaD
